{"name":"GEn1E Lifesciences","slug":"gen1e-lifesciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GEn-1124","genericName":"GEn-1124","slug":"gen-1124","indication":"Metastatic non-small cell lung cancer","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Gen1E-1124","genericName":"Gen1E-1124","slug":"gen1e-1124","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"GEn-1124","genericName":"GEn-1124","slug":"gen-1124","phase":"phase_2","mechanism":"GEn-1124 is a small molecule that targets the PI3K/AKT pathway.","indications":["Metastatic non-small cell lung cancer"],"catalyst":""},{"name":"Gen1E-1124","genericName":"Gen1E-1124","slug":"gen1e-1124","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWjVFUFAyT2dOLUFHQTFQVHFwcURTR2ZYaDNKTHFObUk2VXJyUXdwZ0ZKXzY4dUFjU25Ycjk2SS1ZdkxWbTRRem1kSUdacDhhSFlMZDRRbW1WVjRENVlEWTAtdkhwU0FBTWM5MkdReXlxSm1tTklTNTBPN1ZqNGo5U2VmTEVubHBNQmtYZkZhM3Vza3V1TWtBVFBFZldFTVR5WnJqa1Blc0pncWZxRzNkZWdjUTg5REFfYzNGSlhIREhIVGQtU09V?oc=5","date":"2025-10-28","type":"pipeline","source":"scanx.trade","summary":"Rubicon Research Inks $2.5 Million Stock Purchase Agreement with Neuronasal - scanx.trade","headline":"Rubicon Research Inks $2.5 Million Stock Purchase Agreement with Neuronasal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQRzlJc3hzY1ItbnBYSXRuZWZxdTNjdnZpclctZUR0N1YwVGprVDQ5TVhrRGx2aHQ5Tlp6eFRKd0dGY2k0ZjFTcDZMcHR4UW1qU25sTkJJbUtqbldDZVBDelNkZjNKTEFTOExtSGJUTWJudXplNW84eVFjcXRBNU94dmlxd29xYWlPazgwRFJR?oc=5","date":"2025-10-23","type":"pipeline","source":"Equitypandit","summary":"Stocks in Focus: Torrent Pharma, Dr Reddy’s Lab, and Others - Equitypandit","headline":"Stocks in Focus: Torrent Pharma, Dr Reddy’s Lab, and Others","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNdkdfajA2WHVGTnhkTEFvYzNONE9OanV0UEhrSUVROEVDLWMtYjJtdHV6ZHJWMjZobnE2YWZGaWR5Y0hfU1gwVUhuSUtVcmtFQS1RVHJZazVONk5Nai1KZ1lBUHNLN3ZWT2JmbTNEWU04VElfelVTSGstbjkya19xLThneElYVklkMjJCcWVMc1hLY0F2ZmxnTzFTQUNqRlBlaFJTeE5mVFNybkxwWGpidy1rcHc4d0x5YnRZODBzc2dXR05B?oc=5","date":"2025-10-21","type":"pipeline","source":"scanx.trade","summary":"Rubicon Research Unit Enters Agreement with Gen1E Lifesciences Inc. - scanx.trade","headline":"Rubicon Research Unit Enters Agreement with Gen1E Lifesciences Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNT3E4emY3ekZHbmxBZzZJQ2c2cVJ3SERZTW9yM3dDUWw4azhUOHBGbklwUlZOUEpqQ2h0Q2ZUc2NLaUowd0hFVTJmWWV6TmZ4eFNiY1oyeXZkZG5zZWxOLXc0VU11YVRmQVAyeXZWaEhYcHFxMnBmclBXQkdNWmExZXJtYm1CZlQxelE?oc=5","date":"2024-12-11","type":"pipeline","source":"Yahoo Finance","summary":"GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors - Yahoo Finance","headline":"GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOQzRHZ180LU9zLXQ2R3U4dmN2UHpuUzZhcE9UTEszaWR5Zy1pUWdSb0JQdXBub0pDLXNHZW1HRFZQQUtJZDZfdlN3cWZYMEFYUW9xZDhXUUVJTDNYOVVjZTA2QlN0cEdxWnhJbVAyMjJ5Yzl2RV82Y3Yta05RcTAtazZSY0IybUV6M2gtQ2toeWlFajBXMUdobDdia3pObDkxSV9LdEE5aWl6UVBBbkVDQ3dCS0ctdFh1WGwySElsUWtENDdsekhDaTlpSnhvMFRRbEp0QWx2eFpLQQ?oc=5","date":"2023-10-04","type":"pipeline","source":"elm.umaryland.edu","summary":"Founders Week 2023: David J. Ramsay Entrepreneurs of the Year Jeffrey Hasday, MD, and Paul Shapiro, PhD - elm.umaryland.edu","headline":"Founders Week 2023: David J. Ramsay Entrepreneurs of the Year Jeffrey Hasday, MD, and Paul Shapiro, PhD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQSXpKM2NOTVBnV2hfNW8zZVRZNUFXLS1rS2tKTVB5RG1LVWp4ckg4YzNmMGk3b3lVY3J6bC16VGZndDJoOWNiTTNEbmtjTFpoSzEzR1NmSVVRWUFGTFR3MUZFc1JOclZlNEJsUjBZdW9jdFc5Ymc5RFhYeUFfWVhOWlBZQQ?oc=5","date":"2022-08-03","type":"deal","source":"Technical.ly","summary":"UMB, in partnership with alumni, wants to commercialize rare disease treatments - Technical.ly","headline":"UMB, in partnership with alumni, wants to commercialize rare disease treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdE5tcDZKQ3h4X0lXdU1yU2hSSk9MREJHX3RWT2FkMDBCOE11RVZPUjlyWGUycWlhbTVkYjdlX2pZSUZGVEF2cDFYbVVzMWZYdHZraFIxT0FNNjJabHFrRGtLdm5YUHItZ2RpdmR1TVJKZ0J4OXdCQ0dPam1jR1kwd1dLWXhjYkNVQzZMbjVvVERjZDd4blVmMWk2WERuelA0M1hHYTVzRldwM1VGZEtINElB?oc=5","date":"2019-07-31","type":"pipeline","source":"Fierce Biotech","summary":"Meet GEn1E, the biotech bringing p38alpha kinase drugs to inflammatory diseases - Fierce Biotech","headline":"Meet GEn1E, the biotech bringing p38alpha kinase drugs to inflammatory diseases","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}